17 alpha-hydroxylase deficiency (patient information): Difference between revisions

Jump to navigation Jump to search
Line 6: Line 6:


==Overview==
==Overview==
Symptoms of 17 alpha-hydroxylase  deficiency include delayed puberty and primary amenorrhea. Mutations in the ''CYP17'' gene cause 17 alpha-hydroxylase deficiency. The most potent risk factor in the development of 17 alpha-hydroxylase deficiency is the presence of [[family history]] of 17 alpha-hydroxylase deficiency. Laboratory findings consistent with the diagnosis of 17 alpha-hydroxylase deficiency include elevated 17α-hydroxyprogesterone, elevated androstenedione, elevated urinary 17-ketosteroids and  decreased renin.
Symptoms of 17 alpha-hydroxylase  deficiency include [[delayed puberty]] and [[primary amenorrhea]]. Mutations in the [[CYP17A1|CYP17]] gene cause 17 alpha-hydroxylase deficiency. The most potent risk factor in the development of 17 alpha-hydroxylase deficiency is the presence of [[family history]] of 17 alpha-hydroxylase deficiency. Laboratory findings consistent with the diagnosis of 17 alpha-hydroxylase deficiency include elevated [[17-hydroxyprogesterone|17α-hydroxyprogesterone]], elevated [[androstenedione]], elevated urinary 17-ketosteroids and  decreased [[renin]].
==What are the symptoms of 17 alpha-hydroxylase deficiency?==
==What are the symptoms of 17 alpha-hydroxylase deficiency?==
Symptoms of 17 alpha-hydroxylase  deficiency include delayed puberty and primary amenorrhea
Symptoms of 17 alpha-hydroxylase  deficiency include delayed puberty and primary amenorrhea
Line 35: Line 35:
==Reference==
==Reference==
*[https://ghr.nlm.nih.gov/condition/17-alpha-hydroxylase-17-20-lyase-deficiency NIH]
*[https://ghr.nlm.nih.gov/condition/17-alpha-hydroxylase-17-20-lyase-deficiency NIH]
*[http://www.nlm.nih.gov/medlineplus/ency/article/000411.htm Medlineplus]

Revision as of 18:35, 7 August 2017


Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Mehrian Jafarizade, M.D [2]

For the WikiDoc page for this topic, click here.

Overview

Symptoms of 17 alpha-hydroxylase deficiency include delayed puberty and primary amenorrhea. Mutations in the CYP17 gene cause 17 alpha-hydroxylase deficiency. The most potent risk factor in the development of 17 alpha-hydroxylase deficiency is the presence of family history of 17 alpha-hydroxylase deficiency. Laboratory findings consistent with the diagnosis of 17 alpha-hydroxylase deficiency include elevated 17α-hydroxyprogesterone, elevated androstenedione, elevated urinary 17-ketosteroids and decreased renin.

What are the symptoms of 17 alpha-hydroxylase deficiency?

Symptoms of 17 alpha-hydroxylase deficiency include delayed puberty and primary amenorrhea

What causes 17 alpha-hydroxylase deficiency?

Mutations in the CYP17 gene cause 17 alpha-hydroxylase deficiency.

Who is at highest risk?

The most potent risk factor in the development of 17 alpha-hydroxylase deficiency is the presence of family history of this disease.

Diagnosis

Laboratory findings consistent with the diagnosis of 17 alpha-hydroxylase deficiency include elevated 17α-hydroxyprogesterone, elevated androstenedione, elevated urinary 17-ketosteroids and decreased renin.

When to seek urgent medical care?

A person should seek urgent medical care when there are any complications that arise from 17 alpha-hydroxylase deficiency such as hypertension.

Treatment options

The mainstay of therapy for 17 alpha-hydroxylase is glucocorticoid therapy.

Where to find medical care for 17 alpha-hydroxylase deficiency?

Directions to Hospitals Treating 17 alpha-hydroxylase deficiency

Prevention

Prenatal diagnosis of 17 alpha-hydroxylase deficiency is conducted to prevent complication of the disease in future life and treated with prenatal dexamethasone treatment.

What to expect (Outlook/Prognosis)?

The prognosis of 17 alpha-hydroxylase deficiency is generally good with treatment

Possible complications

Reference